Literature DB >> 33426632

COVID-19 vaccination in immunocompromised patients.

Bhavin Sonani1, Fawad Aslam2, Amandeep Goyal3, Janki Patel4, Pankaj Bansal5.   

Abstract

Entities:  

Year:  2021        PMID： 33426632     DOI： 10.1007/s10067-020-05547-w

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  9 in total

1.  Optimal time between the last methotrexate administration and seasonal influenza vaccination in rheumatoid arthritis: post hoc analysis of a randomised clinical trial.

Authors:  Jin Kyun Park; Yunhee Choi; Kevin L Winthrop; Yeong Wook Song; Eun Bong Lee
Journal:  Ann Rheum Dis       Date:  2019-03-23       Impact factor: 19.103

2.  Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis.

Authors:  Ye Ji Lee; Samuel Bitoun; Jin Kyun Park; Kevin L Winthrop; Yunhee Choi; Eun Bong Lee; Xavier Mariette
Journal:  Ann Rheum Dis       Date:  2018-10-08       Impact factor: 19.103

3.  A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.

Authors:  Sujith Subesinghe; Katie Bechman; Andrew I Rutherford; David Goldblatt; James B Galloway
Journal:  J Rheumatol       Date:  2018-03-15       Impact factor: 4.666

4.  The mortality of rheumatoid arthritis.

Authors:  F Wolfe; D M Mitchell; J T Sibley; J F Fries; D A Bloch; C A Williams; P W Spitz; M Haga; S M Kleinheksel; M A Cathey
Journal:  Arthritis Rheum       Date:  1994-04

5.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01

6.  Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial.

Authors:  Jin Kyun Park; Yun Jong Lee; Kichul Shin; You-Jung Ha; Eun Young Lee; Yeong Wook Song; Yunhee Choi; Kevin L Winthrop; Eun Bong Lee
Journal:  Ann Rheum Dis       Date:  2018-03-23       Impact factor: 19.103

7.  An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Authors:  Lisa A Jackson; Evan J Anderson; Nadine G Rouphael; Paul C Roberts; Mamodikoe Makhene; Rhea N Coler; Michele P McCullough; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian McDermott; Britta Flach; Nicole A Doria-Rose; Kizzmekia S Corbett; Kaitlyn M Morabito; Sijy O'Dell; Stephen D Schmidt; Phillip A Swanson; Marcelino Padilla; John R Mascola; Kathleen M Neuzil; Hamilton Bennett; Wellington Sun; Etza Peters; Mat Makowski; Jim Albert; Kaitlyn Cross; Wendy Buchanan; Rhonda Pikaart-Tautges; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-07-14       Impact factor: 91.245

8.  Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Authors:  Milena Gianfrancesco; Kimme L Hyrich; Jinoos Yazdany; Pedro M Machado; Philip C Robinson; Sarah Al-Adely; Loreto Carmona; Maria I Danila; Laure Gossec; Zara Izadi; Lindsay Jacobsohn; Patricia Katz; Saskia Lawson-Tovey; Elsa F Mateus; Stephanie Rush; Gabriela Schmajuk; Julia Simard; Anja Strangfeld; Laura Trupin; Katherine D Wysham; Suleman Bhana; Wendy Costello; Rebecca Grainger; Jonathan S Hausmann; Jean W Liew; Emily Sirotich; Paul Sufka; Zachary S Wallace
Journal:  Ann Rheum Dis       Date:  2020-05-29       Impact factor: 19.103

9.  COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Authors:  Ugur Sahin; Alexander Muik; Evelyna Derhovanessian; Isabel Vogler; Lena M Kranz; Mathias Vormehr; Alina Baum; Kristen Pascal; Jasmin Quandt; Daniel Maurus; Sebastian Brachtendorf; Verena Lörks; Julian Sikorski; Rolf Hilker; Dirk Becker; Ann-Kathrin Eller; Jan Grützner; Carsten Boesler; Corinna Rosenbaum; Marie-Cristine Kühnle; Ulrich Luxemburger; Alexandra Kemmer-Brück; David Langer; Martin Bexon; Stefanie Bolte; Katalin Karikó; Tania Palanche; Boris Fischer; Armin Schultz; Pei-Yong Shi; Camila Fontes-Garfias; John L Perez; Kena A Swanson; Jakob Loschko; Ingrid L Scully; Mark Cutler; Warren Kalina; Christos A Kyratsous; David Cooper; Philip R Dormitzer; Kathrin U Jansen; Özlem Türeci
Journal:  Nature       Date:  2020-09-30       Impact factor: 49.962
  9 in total
  24 in total

1.  Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease.

Authors:  Pankti Mehta; Aby Paul; Sakir Ahmed; Somy Cherian; Ameya Panthak; Janet Benny; Padmanabha Shenoy
Journal:  Clin Rheumatol       Date:  2022-06-28       Impact factor: 3.650

2.  Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.

Authors:  Paul J Thuluvath; Polly Robarts; Mahak Chauhan
Journal:  J Hepatol       Date:  2021-08-26       Impact factor: 25.083

3.  Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.

Authors:  Dan Cohen; Shir Hazut Krauthammer; Yael C Cohen; Chava Perry; Irit Avivi; Yair Herishanu; Einat Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-08       Impact factor: 9.236

Review 4.  Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID-19 pandemic.

Authors:  Lai-Shan Tam; Yoshiya Tanaka; Rohini Handa; Zhanguo Li; Jose Paulo Lorenzo; Worawit Louthrenoo; Catherine Hill; Kevin Pile; Philip C Robinson; Leonila F Dans; Li Yang Hsu; Sang-Min Lee; Jiacai Cho; A T M Tanveer Hasan; Babur Salim; Saba Samreen; Syahrul Sazliyana Shaharir; Priscilla Wong; Jeffrey Chau; Debashish Danda; Syed Atiqul Haq
Journal:  Int J Rheum Dis       Date:  2021-05-04       Impact factor: 2.454

Review 5.  Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic.

Authors:  P Devnath; H M A A Masud
Journal:  New Microbes New Infect       Date:  2021-03-19

Review 6.  Review the safety of Covid-19 mRNA vaccines: a review.

Authors:  Pratibha Anand; Vincent P Stahel
Journal:  Patient Saf Surg       Date:  2021-05-01

Review 7.  SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches.

Authors:  Olivia Swain; Sofia K Romano; Ritika Miryala; Jocelyn Tsai; Vinnie Parikh; George K E Umanah
Journal:  J Neurosci       Date:  2021-06-23       Impact factor: 6.167

8.  SARS-CoV-2 vaccine breakthrough infections among healthcare workers in a large Belgian hospital network.

Authors:  Dieter Geysels; Pierre Van Damme; Walter Verstrepen; Peggy Bruynseels; Bea Janssens; Patrick Smits; Reinout Naesens
Journal:  Infect Control Hosp Epidemiol       Date:  2021-07-22       Impact factor: 3.254

Review 9.  Keep out! SARS-CoV-2 entry inhibitors: their role and utility as COVID-19 therapeutics.

Authors:  Lennox Chitsike; Penelope Duerksen-Hughes
Journal:  Virol J       Date:  2021-07-23       Impact factor: 4.099

10.  Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.

Authors:  Nevin Hammam; Samar Tharwat; Rawhya R El Shereef; Ahmed M Elsaman; Noha M Khalil; Hanan M Fathi; Mohamed N Salem; Hanan M El-Saadany; Nermeen Samy; Amany S El-Bahnasawy; Yousra H Abdel-Fattah; Marwa A Amer; Emad ElShebini; Amira T El-Shanawany; Dina H El-Hammady; Rasha Abdel Noor; Marwa ElKhalifa; Faten Ismail; Rasha M Fawzy; Amany R El-Najjar; Zahraa I Selim; Nouran M Abaza; Ahmed R Radwan; Mervat IAbd Elazeem; Wael Abdel Mohsen; Abdel Hafeez Moshrif; Eman F Mohamed; Loay I Aglan; Soha Senara; Maha E Ibrahim; Iman Khalifa; Rasha El Owaidy; Noha El Fakharany; Reem Hamdy A Mohammed; Tamer A Gheita
Journal:  Rheumatol Int       Date:  2021-07-09       Impact factor: 2.631
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.